BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31578445)

  • 1. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells.
    Riedel R; Pérez-Pérez A; Carmona-Fernández A; Jaime M; Casale R; Dueñas JL; Guadix P; Sánchez-Margalet V; Varone CL; Maymó JL
    Sci Rep; 2019 Oct; 9(1):14193. PubMed ID: 31578445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression.
    Bao T; Ke Y; Wang Y; Wang W; Li Y; Wang Y; Kui X; Zhou Q; Zhou H; Zhang C; Zhou D; Wang L; Xiao C
    J Mol Med (Berl); 2018 Jul; 96(7):661-672. PubMed ID: 29806073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
    Zhao H; Zhang Y; Sun J; Zhan C; Zhao L
    Oncol Res; 2016; 23(5):237-48. PubMed ID: 27098147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
    Hong M; Almutairi MM; Li S; Li J
    Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
    Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
    Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bauerenol, a triterpenoid from Indian Suregada angustifolia: Induces reactive oxygen species-mediated P38MAPK activation and apoptosis in human hepatocellular carcinoma (HepG2) cells.
    Sathish Kumar P; Viswanathan MBG; Venkatesan M; Balakrishna K
    Tumour Biol; 2017 Apr; 39(4):1010428317698387. PubMed ID: 28443465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.
    Xiao Z; Li CH; Chan SL; Xu F; Feng L; Wang Y; Jiang JD; Sung JJ; Cheng CH; Chen Y
    Cancer Res; 2014 Nov; 74(21):6236-47. PubMed ID: 25217526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
    Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
    Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
    Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
    Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2.
    Deng P; Wang C; Chen L; Wang C; Du Y; Yan X; Chen M; Yang G; He G
    Biol Pharm Bull; 2013; 36(10):1540-8. PubMed ID: 24088253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
    Huang H; Hu M; Zhao R; Li P; Li M
    Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.
    Feng YM; Feng CW; Chen SY; Hsieh HY; Chen YH; Hsu CD
    BMC Cancer; 2015 Mar; 15():134. PubMed ID: 25886177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
    J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abieslactone induces cell cycle arrest and apoptosis in human hepatocellular carcinomas through the mitochondrial pathway and the generation of reactive oxygen species.
    Wang GW; Lv C; Shi ZR; Zeng RT; Dong XY; Zhang WD; Liu RH; Shan L; Shen YH
    PLoS One; 2014; 9(12):e115151. PubMed ID: 25502685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.